Sotera Health Co (SHC)
11.19
+0.10
(+0.90%)
USD |
NASDAQ |
May 31, 16:00
11.19
0.00 (0.00%)
After-Hours: 20:00
Sotera Health Cash from Investing (Quarterly): -34.85M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -34.85M |
| December 31, 2023 | -64.83M |
| September 30, 2023 | -51.98M |
| June 30, 2023 | -53.13M |
| March 31, 2023 | -44.97M |
| December 31, 2022 | -71.74M |
| September 30, 2022 | -38.97M |
| June 30, 2022 | -35.71M |
| March 31, 2022 | -35.48M |
| Date | Value |
|---|---|
| December 31, 2021 | -72.26M |
| September 30, 2021 | -16.60M |
| June 30, 2021 | -24.46M |
| March 31, 2021 | -46.52M |
| December 31, 2020 | -18.77M |
| September 30, 2020 | -116.48M |
| June 30, 2020 | -10.45M |
| March 31, 2020 | -12.99M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-116.48M
Minimum
Sep 2020
-10.45M
Maximum
Jun 2020
-44.13M
Average
-38.97M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Fonar Corp | -0.289M |
| XWELL Inc | -0.371M |
| ProPhase Labs Inc | 2.435M |
| Applied DNA Sciences Inc | -0.0148M |
| Veracyte Inc | 2.878M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.699M |
| Cash from Financing (Quarterly) | -11.94M |
| Free Cash Flow | -376.77M |
| Free Cash Flow Per Share (Quarterly) | -0.0887 |
| Free Cash Flow to Equity (Quarterly) | -26.14M |
| Free Cash Flow to Firm (Quarterly) | -1.211M |
| Free Cash Flow Yield | -11.90% |